The Latest Breaking News from Weight Loss

The price hike is not expected to affect access for patients who receive Mounjaro through the National Health Service (NHS).

Doctor and competitor Marlen Reusser says Ferrand-Prévot’s weight loss sets a worrying standard for the peloton

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant of bribing medical providers to promote its most profitable drugs, including the widely used GLP-1 medications Mounjaro and Zepbound for diabetes and weight loss.

Women who took part in a weight loss programme had a 21 per cent higher chance of becoming pregnant – whether naturally or through IVF

Altimmune, Inc. (NASDAQ:ALT) reported its second-quarter financial results before Tuesday’s opening bell.

Around one in five women of childbearing age are living with [obesity], defined by the World Health Organization as having a body mass index (BMI) over 30 kg/m². Compared with women in the healthy BMI range (18.5–24.9 kg/m²), those living with obesity are three times more likely to experience fertility…

IN FULL

A woman uttered five striking words to her family from her hospital bed before she died of complications arising from her pursuit of a healthier life.

Trump’s plan to cover weight loss drugs under Medicaid programs and Medicare Part D plans to could be a major tailwind for LLY and NVO, despite tarrif threats.

Weight loss drug goliath Eli Lilly just tanked despite posting impressive Q2 results. See what drove the decline and whether the market reaction is overdone.

Doctors from only four medical specialties will be able to write prescriptions for injectable drugs that are used to treat type 2 diabetes and obesity but are also popular for weight loss.